CD28-ARS2 Axis Drives Metabolic Flexibility in CD8+ T Cells
2026-06-26
The referenced study uncovers a novel CD28-ARS2 signaling axis that modulates alternative splicing of pyruvate kinase (PKM), enabling CD8+ T cells to adapt glucose metabolism for enhanced antitumor immunity. This work advances understanding of immunometabolic regulation by revealing that splicing events, rather than canonical PI3K pathways, critically determine effector T cell metabolic flexibility.
Discovery of Potent Cas9 Inhibitors via Functional Metagenom
2026-06-25
Forsberg et al. present a high-throughput functional metagenomic strategy to uncover diverse anti-CRISPR proteins from the human microbiome, notably identifying AcrIIA11 as a potent Cas9 inhibitor. This work expands the known repertoire of Cas9 antagonists and provides a robust framework for further exploration of microbial immune modulation.
Acetylcysteine in 3D Tumor Models: Protocols and Innovations
2026-06-25
Acetylcysteine (N-acetyl-L-cysteine) empowers researchers to dissect chemoresistance and oxidative stress in patient-derived 3D cancer models. This guide delivers actionable protocols, troubleshooting, and workflow enhancements, drawing on recent advances in co-culture systems and data-driven assay design.
Dabigatran Etexilate: Redefining Oral Anticoagulation in VTE
2026-06-24
Dabigatran etexilate introduces a new paradigm in oral anticoagulation by directly inhibiting thrombin without involving CYP3A metabolism, as detailed in the reference review. Its predictable pharmacokinetics, reduced need for monitoring, and oral administration address major limitations of traditional agents and inform both clinical and pharmacokinetic research strategies.
Inonotus obliquus Polysaccharide Attenuates RA via NF-κB/NLR
2026-06-23
This study integrates network pharmacology and experimental validation to demonstrate that Inonotus obliquus polysaccharide (IOP) alleviates rheumatoid arthritis (RA) by targeting NF-κB and NLRP3 inflammasome pathways. The findings provide mechanistic insight and preclinical evidence for the anti-inflammatory potential of IOP in RA management.
Amikacin Sulfate: Optimizing Intracellular NTM Research Work
2026-06-23
Amikacin Sulfate stands out for targeted, dose-dependent eradication of non-tuberculous mycobacteria, excelling in both in vitro and in vivo models. This article demystifies workflow optimization, from advanced delivery strategies to troubleshooting, ensuring researchers harness APExBIO’s Amikacin Sulfate for maximal efficacy and translational precision.
Oxaliplatin: Platinum-Based Chemotherapeutic Agent in Cancer
2026-06-22
Oxaliplatin stands out as a platinum-based chemotherapeutic agent with robust efficacy in both in vitro and in vivo cancer models. This guide translates recent findings into practical protocols, highlights troubleshooting strategies, and demonstrates how to maximize Oxaliplatin’s value in apoptosis induction and metastatic colorectal cancer research.
Astrocytic GAT-3 Modulation of Synaptic Transmission in the
2026-06-22
The reference study identifies astrocytic GAT-3 as a key regulator of synaptic transmission and contextual memory formation in the dentate gyrus (DG) of the hippocampus. By dissecting the pathway from GABAergic signaling to astrocytic calcium dynamics and excitatory neurotransmission, the work provides mechanistic insight with implications for cognitive research and potential therapeutic targets.
NAD+/NADH Balance Guides Hypoxic Adaptation in Filamentous F
2026-06-21
The referenced study elucidates how NAD+/NADH homeostasis underpins metabolic adaptation to hypoxia in filamentous fungi, impacting energy conservation and secondary metabolite biosynthesis. These findings offer mechanistic insight crucial for both industrial fermentation optimization and fundamental redox biology.
Annexin V-PE Reagent: Advanced Apoptosis Detection and Workf
2026-06-20
The Annexin V-PE Reagent enables rapid, sensitive, and reproducible detection of early apoptosis, streamlining cell death assays for both basic and translational research. Its one-step protocol and robust performance empower precise phosphatidylserine externalization detection, addressing key challenges in CAR-T development and immunotherapy workflows.
Transmission Dynamics of Carbapenemase Genes in CREC, Guangd
2026-06-19
This study provides the first comprehensive molecular epidemiology of carbapenemase-encoding genes (CEGs) in carbapenem-resistant Enterobacter cloacae (CREC) across eight hospitals in Guangdong, China (2022–2024). The work reveals high prevalence and transferability of plasmid-borne blaNDM-1, multidrug resistance patterns, and risk factors for CEG dissemination, informing antibiotic resistance research and clinical surveillance.
Perospirone (SM-9018 Free Base): Applied Research and Protoc
2026-06-19
Perospirone (SM-9018 free base) advances schizophrenia and neuropsychiatric research through its high-affinity serotonergic and dopaminergic receptor targeting and newly documented vascular Kv1.5 channel inhibition. This article delivers actionable experimental protocols, troubleshooting tactics, and insight into cross-domain research enabled by this versatile agent.
Protease Inhibitor Cocktail (EDTA-Free): Optimizing Protein
2026-06-18
Discover how the Protease Inhibitor Cocktail (EDTA-Free, 100X in DMSO) enhances protein stability for OXPHOS research and advanced cancer assays. This article provides new insights into protocol design, workflow integration, and mechanistic considerations, distinguishing itself from prior guides.
TG003 and the Future of Alternative Splicing Modulation in C
2026-06-18
Explore how TG003, a potent Cdc2-like kinase inhibitor, advances alternative splicing modulation and platinum resistance research. This article uniquely analyzes translational evidence, protocol precision, and the evolving impact of Clk inhibition in oncology.
Metagenomic Discovery of Potent Cas9 Inhibitors in the Micro
2026-06-17
Forsberg et al. introduce a functional metagenomics approach to identify potent anti-CRISPR proteins that inhibit Cas9, uncovering AcrIIA11 as a widely distributed inhibitor in the human microbiome. Their work provides new molecular tools for understanding CRISPR-Cas dynamics and highlights untapped functional diversity within microbiome-derived genetic material.
461 records 14/31 page Previous Next First page 上5页 1112131415 下5页 Last page